+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

Integrin alpha4beta1 antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Integrin alpha4beta1 antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
PULMOZYME Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

PULMOZYME Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
Dupilumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Dupilumab Emerging Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
From
Asthma - Competitive landscape, 2023 - Product Thumbnail Image

Asthma - Competitive landscape, 2023

  • Report
  • April 2023
  • 240 Pages
  • Global
From
From
Respiratory Syncytial Virus (RSV) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) - Epidemiology Forecast - 2032

  • Report
  • February 2023
  • 82 Pages
  • Global
From
XOLAIR Marketed Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

XOLAIR Marketed Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
Benralizumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Benralizumab Emerging Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
From
From
From
XOLAIR Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

XOLAIR Emerging Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
From
From
From
Nasal Polyposis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Nasal Polyposis - Epidemiology Forecast - 2032

  • Report
  • August 2022
  • 80 Pages
  • Global
From
Severe Asthma - Epidemiology Forecast - 2032 - Product Thumbnail Image

Severe Asthma - Epidemiology Forecast - 2032

  • Report
  • June 2022
  • 95 Pages
  • Global
From
Bronchopulmonary Dysplasia - Epidemiology Forecast - 2032 - Product Thumbnail Image

Bronchopulmonary Dysplasia - Epidemiology Forecast - 2032

  • Drug Pipelines
  • March 2022
  • 62 Pages
  • Global
From
Bronchiolitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Bronchiolitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more